Prognostic value of NT-ProBNP/BNP ratio in patients with heart failure and reduced ejection fraction using sacubitril-valsartan: systematic review and post hoc analysis of PARADIGM-HF Trial

被引：0
|
作者：
Eduardo Pitthan, E. [1 ]
Hirakata, V. N. [1 ]
Barbisan, J. N. [1 ]
Rodrigues, C. G. [1 ]
机构：
[1] Inst Cardiol Rio Grande Do Sul, Porto Alegre, RS, Brazil
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1011
引用
收藏
页码：245 / 245
页数：1
相关论文
共 50 条
  • [31] Sacubitril/valsartan: from the PARADIGM-HF trial results to heart failure patients in internal medicine. A narrative review
    Verdiani, Valerio
    ITALIAN JOURNAL OF MEDICINE, 2021, 15 (01) : 17 - 26
  • [32] Sacubitril/valsartan and arrhythmic burden in patients with heart failure and reduced ejection fraction: a systematic review and meta-analysis
    Pozzi, A.
    Abete, R.
    Tavano, E.
    Kristensen, S. L.
    Rea, F.
    Iorio, A.
    Iacovoni, A.
    Corrado, G.
    Wong, C.
    HEART FAILURE REVIEWS, 2023, 28 (06) : 1395 - 1403
  • [33] Sacubitril/valsartan and arrhythmic burden in patients with heart failure and reduced ejection fraction: a systematic review and meta-analysis
    A. Pozzi
    R. Abete
    E. Tavano
    S. L. Kristensen
    F. Rea
    A. Iorio
    A. Iacovoni
    G. Corrado
    C. Wong
    Heart Failure Reviews, 2023, 28 : 1395 - 1403
  • [34] Cost-Effectiveness Analysis of Sacubitril-Valsartan Compared with Enalapril in Patients with Heart Failure with Reduced Ejection Fraction in Thailand
    Rungroj Krittayaphong
    Unchalee Permsuwan
    American Journal of Cardiovascular Drugs, 2018, 18 : 405 - 413
  • [35] Cost-Effectiveness Analysis of Sacubitril-Valsartan Compared with Enalapril in Patients with Heart Failure with Reduced Ejection Fraction in Thailand
    Krittayaphong, Rungroj
    Permsuwan, Unchalee
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2018, 18 (05) : 405 - 413
  • [36] Efficacy and safety of sacubitril/valsartan according to frailty in heart failure with preserved ejection fraction: a post hoc analysis of the PARAGON-HF trial
    Butt, J. H.
    Dewan, P.
    Kober, L.
    Jhund, P. S.
    Solomon, S. D.
    McMurray, J. J. V.
    EUROPEAN HEART JOURNAL, 2022, 43 : 1052 - 1052
  • [37] Effects of Sacubitril/Valsartan on Physical and Social Activity Limitations in Patients With Heart Failure A Secondary Analysis of the PARADIGM-HF Trial
    Chandra, Alvin
    Lewis, Eldrin F.
    Claggett, Brian L.
    Desai, Akshay S.
    Packer, Milton
    Zile, Michael R.
    Swedberg, Karl
    Rouleau, Jean L.
    Shi, Victor C.
    Lefkowitz, Martin P.
    Katova, Tzvetana
    McMurray, John J., V
    Solomon, Scott D.
    JAMA CARDIOLOGY, 2018, 3 (06) : 498 - 505
  • [38] Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial
    Desai, Akshay S.
    Solomon, Scott D.
    Shah, Amil M.
    Claggett, Brian L.
    Fang, James C.
    Izzo, Joseph
    McCague, Kevin
    Abbas, Cheryl A.
    Rocha, Ricardo
    Mitchell, Gary F.
    Izzo, Joseph
    Martinez-Castrillon, Melvin
    Beato, Jorge
    Shah, Vipul
    Pianko, Leonard
    Bouza, Manuel
    Alhaddad, Mohsin
    Kashani, Amir
    Sampognaro, Gregory
    Stahl, Lloyd
    Lehman, John
    Lebhar, Steve
    Napoli, Mark
    Consuegra, Aurelio Torres
    Gonzalez, Humberto
    Lloret, Ramon
    Ariani, Mehrdad
    Azizad, Masoud
    Shah, Anil
    Henderson, David
    Covalesky, John
    Brabham, David
    Chane, Majed
    Sanchez, Eulogio
    Vega, Ramses
    Clay, Anthony
    McClure, John
    Sogade, Felix
    Ortiz-Munoz, Luis
    Lewis, Todd
    Zequeira, Argentina Gonzalez
    Shah, Rakesh
    Lepor, Norman
    Gonzalez, Marisela
    Tidman, Raymond
    Berman, Jeffrey
    Lorenz, David
    Nanna, Michele
    Greene, Trevor
    Portnay, Edward
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (11): : 1077 - 1084
  • [39] Safety and tolerability of sacubitril/valsartan in chronic heart failure and reduced ejection fraction: Results from the open-label extension of the PARADIGM-HF study
    Senni, Michele
    Paruchuru, Pratap
    Shi, Victor
    Boehm, Michael
    EUROPEAN JOURNAL OF HEART FAILURE, 2025,
  • [40] Efficacy and safety of sacubitril/valsartan compared with enalapril in patients with chronic heart failure and reduced ejection fraction: Results from PARADIGM-HF India sub-study
    Jain, Anil Ranjeetmal
    Aggarwal, Rakesh Kumar
    Rao, Nanyam Srinivas
    Billa, Gauri
    Kumar, Shankar
    INDIAN HEART JOURNAL, 2020, 72 (06) : 535 - 540
12345